{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:03Z","timestamp":1793726463726,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41434-026-00599-0","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T04:11:45Z","timestamp":1772683905000},"page":"448-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro and in vivo rescue of dopaminergic neurons in Parkinson\u2019s disease models after Parkin gene therapy"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1772-1221","authenticated-orcid":false,"given":"Takeshi","family":"Hioki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Melissa","family":"Jacobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Okai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Proetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00702-017-1742-7","volume":"124","author":"N Hattori","year":"2017","unstructured":"Hattori N, Mizuno Y. Twenty years since the discovery of the parkin gene. J Neural Transm (Vienna). 2017;124:1037\u201354.","journal-title":"J Neural Transm (Vienna)"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of Parkinson\u2019s disease: Contributions and global trends. J Hum Genet. 2023;68:125\u201330.","journal-title":"J Hum Genet"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature. 1998;392:605\u20138.","journal-title":"Nature"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"CB L\u00fccking","year":"2000","unstructured":"L\u00fccking CB, D\u00fcrr A, Bonifati V, Vaughan J, De Michele G, Gasser T, et al. Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene. N Engl J Med. 2000;342:1560\u20137.","journal-title":"N Engl J Med"},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jamaneurol.2013.488","volume":"70","author":"A Gr\u00fcnewald","year":"2013","unstructured":"Gr\u00fcnewald A, Kasten M, Ziegler A, Klein C. Next-generation phenotyping using the parkin example: time to catch up with genetics. JAMA Neurol. 2013;70:1186\u201391.","journal-title":"JAMA Neurol"},{"key":"599_CR6","unstructured":"Diogo D, Wong EHM, DeBoever C, Qu W, Lee J, Crawford S, et al. Estimated genetics prevalence of early-onset Parkinson\u2019s disease caused by PRKN gene mutations. medRxiv."},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt EJ, et al. Genotype-Phenotype Relations for the Parkinson\u2019s Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review. Mov Disord. 2018;33:730\u201341.","journal-title":"Mov Disord"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/brain\/awg142","volume":"126","author":"NL Khan","year":"2003","unstructured":"Khan NL, Graham E, Critchley P, Schrag AE, Wood NW, Lees AJ, et al. Parkin disease: a phenotypic study of a large case series. Brain. 2003;126:1279\u201392.","journal-title":"Brain"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1212\/WNL.47.1.160","volume":"47","author":"A Ishikawa","year":"1996","unstructured":"Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology. 1996;47:160\u20136.","journal-title":"Neurology"},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.201410050","volume":"209","author":"K Okatsu","year":"2015","unstructured":"Okatsu K, Koyano F, Kimura M, Kosako H, Saeki Y, Tanaka K, et al. Phosphorylated ubiquitin chain is the genuine Parkin receptor. J Cell Biol. 2015;209:111\u201328.","journal-title":"J Cell Biol"},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"e1004861","DOI":"10.1371\/journal.pgen.1004861","volume":"10","author":"K Shiba-Fukushima","year":"2014","unstructured":"Shiba-Fukushima K, Arano T, Matsumoto G, Inoshita T, Yoshida S, Ishihama Y, et al. Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering. PLoS Genet. 2014;10:e1004861.","journal-title":"PLoS Genet"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183:795\u2013803.","journal-title":"J Cell Biol"},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol. 2010;189:211\u201321.","journal-title":"J Cell Biol"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/jb\/mvv125","volume":"159","author":"N Matsuda","year":"2016","unstructured":"Matsuda N. Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade. J Biochem. 2016;159:379\u201385.","journal-title":"J Biochem"},{"key":"599_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2023.102720","volume":"80","author":"SL Pereira","year":"2023","unstructured":"Pereira SL, Grossmann D, Delcambre S, Hermann A, Gr\u00fcnewald A. Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Curr Opin Neurobiol. 2023;80:102720.","journal-title":"Curr Opin Neurobiol"},{"key":"599_CR16","doi-asserted-by":"crossref","unstructured":"Choong CJ, Mochizuki H. Involvement of Mitochondria in Parkinson\u2019s Disease. Int J Mol Sci. 2023;24:17027.","DOI":"10.3390\/ijms242317027"},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z","volume":"45","author":"H Shimura","year":"1999","unstructured":"Shimura H, Hattori N, Kubo S, Yoshikawa M, Kitada T, Matsumine H, et al. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol. 1999;45:668\u201372.","journal-title":"Ann Neurol"},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/mds.28521","volume":"36","author":"N Seike","year":"2021","unstructured":"Seike N, Yokoseki A, Takeuchi R, Saito K, Miyahara H, Miyashita A, et al. Genetic Variations and Neuropathologic Features of Patients with PRKN Mutations. Mov Disord. 2021;36:1634\u201343.","journal-title":"Mov Disord"},{"key":"599_CR19","first-page":"3172","volume":"26","author":"K Shiba-Fukushima","year":"2017","unstructured":"Shiba-Fukushima K, Ishikawa KI, Inoshita T, Izawa N, Takanashi M, Sato S, et al. Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson\u2019s disease. Hum Mol Genet. 2017;26:3172\u201385.","journal-title":"Hum Mol Genet"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/febs.13249","volume":"282","author":"M Seirafi","year":"2015","unstructured":"Seirafi M, Kozlov G, Gehring K. Parkin structure and function. Febs j. 2015;282:2076\u201388.","journal-title":"Febs j"},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaneurol.2013.172","volume":"70","author":"KM Doherty","year":"2013","unstructured":"Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, et al. Parkin disease: a clinicopathologic entity? JAMA Neurol. 2013;70:571\u20139.","journal-title":"JAMA Neurol"},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/NEN.0b013e3182269ecd","volume":"70","author":"T Yasuda","year":"2011","unstructured":"Yasuda T, Hayakawa H, Nihira T, Ren YR, Nakata Y, Nagai M, et al. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2011;70:686\u201397.","journal-title":"J Neuropathol Exp Neurol"},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1089\/hum.2005.16.262","volume":"16","author":"M Yamada","year":"2005","unstructured":"Yamada M, Mizuno Y, Mochizuki H. Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson\u2019s disease. Hum Gene Ther. 2005;16:262\u201370.","journal-title":"Hum Gene Ther"},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/sj.mt.6300067","volume":"15","author":"JC Paterna","year":"2007","unstructured":"Paterna JC, Leng A, Weber E, Feldon J, B\u00fceler H. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther. 2007;15:698\u2013704.","journal-title":"Mol Ther"},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","volume":"14","author":"L Vercammen","year":"2006","unstructured":"Vercammen L, Van der Perren A, Vaudano E, Gijsbers R, Debyser Z, Van den Haute C, et al. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson\u2019s disease. Mol Ther. 2006;14:716\u201323.","journal-title":"Mol Ther"},{"key":"599_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1193","volume":"6","author":"E Chung","year":"2020","unstructured":"Chung E, Choi Y, Park J, Nah W, Park J, Jung Y, et al. Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological \u03b1-synuclein. Sci Adv. 2020;6:eaba1193.","journal-title":"Sci Adv"},{"key":"599_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54066-0","volume":"14","author":"J Cui","year":"2024","unstructured":"Cui J, Zhao D, Xu M, Li Z, Qian J, Song N, et al. Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice. Sci Rep. 2024;14:3721.","journal-title":"Sci Rep"},{"key":"599_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H, et al. Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun. 2014;2:88.","journal-title":"Acta Neuropathol Commun"},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","volume":"22","author":"SJ Gray","year":"2011","unstructured":"Gray SJ, Foti SB, Schwartz JW, Bachaboina L, Taylor-Blake B, Coleman J, et al. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther. 2011;22:1143\u201353.","journal-title":"Hum Gene Ther"},{"key":"599_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.7150\/ijms.8033","volume":"11","author":"C Zheng","year":"2014","unstructured":"Zheng C, Baum BJ. All human EF1\u03b1 promoters are not equal: markedly affect gene expression in constructs from different sources. Int J Med Sci. 2014;11:404\u20138.","journal-title":"Int J Med Sci"},{"key":"599_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymthe.2005.08.012","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA, et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther. 2006;13:391\u2013400.","journal-title":"Mol Ther"},{"key":"599_CR32","doi-asserted-by":"publisher","first-page":"e5046","DOI":"10.1371\/journal.pone.0005046","volume":"4","author":"H Kita-Matsuo","year":"2009","unstructured":"Kita-Matsuo H, Barcova M, Prigozhina N, Salomonis N, Wei K, Jacot JG, et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One. 2009;4:e5046.","journal-title":"PLoS One"},{"key":"599_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.neuroscience.2009.03.032","volume":"161","author":"JL Nathanson","year":"2009","unstructured":"Nathanson JL, Yanagawa Y, Obata K, Callaway EM. Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors. Neuroscience. 2009;161:441\u201350.","journal-title":"Neuroscience"},{"key":"599_CR34","doi-asserted-by":"publisher","first-page":"18206","DOI":"10.1073\/pnas.0407976101","volume":"101","author":"T Dittgen","year":"2004","unstructured":"Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, et al. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci USA. 2004;101:18206\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"599_CR35","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0006-291X(88)81022-2","volume":"157","author":"GT Coker 3rd","year":"1988","unstructured":"Coker GT 3rd, Vinnedge L, O\u2019Malley KL. Characterization of rat and human tyrosine hydroxylase genes: functional expression of both promoters in neuronal and non-neuronal cell types. Biochem Biophys Res Commun. 1988;157:1341\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"599_CR36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1006\/bbrc.2001.5490","volume":"286","author":"S Asakawa","year":"2001","unstructured":"Asakawa S, Tsunematsu K, Takayanagi A, Sasaki T, Shimizu A, Shintani A, et al. The genomic structure and promoter region of the human parkin gene. Biochem Biophys Res Commun. 2001;286:863\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"599_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/sj.gt.3302142","volume":"11","author":"TC Harding","year":"2004","unstructured":"Harding TC, Koprivnikar KE, Tu GH, Zayek N, Lew S, Subramanian A, et al. Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. Gene Ther. 2004;11:204\u201313.","journal-title":"Gene Ther"},{"key":"599_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/75087","volume":"6","author":"L Sun","year":"2000","unstructured":"Sun L, Li J, Xiao X. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med. 2000;6:599\u2013602.","journal-title":"Nat Med"},{"key":"599_CR39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"599_CR40","unstructured":"Shoji M Method for producing dopaminergic neurons. JP6419073, US10017734."},{"key":"599_CR41","doi-asserted-by":"crossref","unstructured":"Naito Y, Sakamoto S, Kojima T, Homma M, Tanaka M, Matsui H. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells. SLAS Discov. 2023,28:344\u20139.","DOI":"10.1016\/j.slasd.2023.06.002"},{"key":"599_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-5-35","volume":"5","author":"Y Imaizumi","year":"2012","unstructured":"Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, et al. Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain. 2012;5:35.","journal-title":"Mol Brain"},{"key":"599_CR43","unstructured":"Nonaka T, Watanabe S, Masuda M, Hasegawa M. Cell into which protein, which can serve as polymerization nucleus of protein polymer, or polymer thereof is introduced, and method for production of the cell (JP5665258). In: Tokyo Metropolitan Institute of Medical Science, (ed), 2006."},{"key":"599_CR44","doi-asserted-by":"publisher","first-page":"18675","DOI":"10.1074\/jbc.M116.734707","volume":"291","author":"A Tarutani","year":"2016","unstructured":"Tarutani A, Suzuki G, Shimozawa A, Nonaka T, Akiyama H, Hisanaga S, et al. The Effect of Fragmented Pathogenic \u03b1-Synuclein Seeds on Prion-like Propagation. J Biol Chem. 2016;291:18675\u201388.","journal-title":"J Biol Chem"},{"key":"599_CR45","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1172\/JCI68205","volume":"123","author":"SM Faust","year":"2013","unstructured":"Faust SM, Bell P, Cutler BJ, Ashley SN, Zhu Y, Rabinowitz JE, et al. CpG-depleted adeno-associated virus vectors evade immune detection. J Clin Invest. 2013;123:2994\u20133001.","journal-title":"J Clin Invest"},{"key":"599_CR46","doi-asserted-by":"publisher","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu K. A guide to neurotoxic animal models of Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2011;1:a009316.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"599_CR47","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00401-021-02285-4","volume":"141","author":"JM Tokarew","year":"2021","unstructured":"Tokarew JM, El-Kodsi DN, Lengacher NA, Fehr TK, Nguyen AP, Shutinoski B, et al. Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites. Acta Neuropathol. 2021;141:725\u201354.","journal-title":"Acta Neuropathol"},{"key":"599_CR48","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cell.2020.04.025","volume":"181","author":"H Katayama","year":"2020","unstructured":"Katayama H, Hama H, Nagasawa K, Kurokawa H, Sugiyama M, Ando R, et al. Visualizing and Modulating Mitophagy for Therapeutic Studies of Neurodegeneration. Cell. 2020;181:1176\u201387.e16.","journal-title":"Cell"},{"key":"599_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"599_CR50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fnins.2019.00595","volume":"13","author":"A Shimozawa","year":"2019","unstructured":"Shimozawa A, Fujita Y, Kondo H, Takimoto Y, Terada M, Sanagi M, et al. Effect of L-DOPA\/Benserazide on Propagation of Pathological \u03b1-Synuclein. Front Neurosci. 2019;13:595.","journal-title":"Front Neurosci"},{"key":"599_CR51","doi-asserted-by":"publisher","first-page":"e39953","DOI":"10.1371\/journal.pone.0039953","volume":"7","author":"M Bian","year":"2012","unstructured":"Bian M, Liu J, Hong X, Yu M, Huang Y, Sheng Z, et al. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. PLoS One. 2012;7:e39953.","journal-title":"PLoS One"},{"key":"599_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/NEN.0000000000000039","volume":"73","author":"AS Van Rompuy","year":"2014","unstructured":"Van Rompuy AS, Lobbestael E, Van der Perren A, Van den Haute C, Baekelandt V. Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration. J Neuropathol Exp Neurol. 2014;73:159\u201374.","journal-title":"J Neuropathol Exp Neurol"},{"key":"599_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbrc.2016.12.188","volume":"483","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, Akamatsu W, Kisa F, Sone T, Ishikawa KI, Kuzumaki N, et al. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons. Biochem Biophys Res Commun. 2017;483:88\u201393.","journal-title":"Biochem Biophys Res Commun"},{"key":"599_CR54","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/hmg\/ddz080","volume":"28","author":"W Yi","year":"2019","unstructured":"Yi W, MacDougall EJ, Tang MY, Krahn AI, Gan-Or Z, Trempe JF, et al. The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson\u2019s disease. Hum Mol Genet. 2019;28:2811\u201325.","journal-title":"Hum Mol Genet"},{"key":"599_CR55","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1080\/15548627.2018.1461294","volume":"14","author":"X Hou","year":"2018","unstructured":"Hou X, Fiesel FC, Truban D, Castanedes Casey M, Lin WL, Soto AI, et al. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. Autophagy. 2018;14:1404\u201318.","journal-title":"Autophagy"},{"key":"599_CR56","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","volume":"33","author":"DI Dryanovski","year":"2013","unstructured":"Dryanovski DI, Guzman JN, Xie Z, Galteri DJ, Volpicelli-Daley LA, Lee VM, et al. Calcium entry and \u03b1-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J Neurosci. 2013;33:10154\u201364.","journal-title":"J Neurosci"},{"key":"599_CR57","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","volume":"74","author":"V Tapias","year":"2017","unstructured":"Tapias V, Hu X, Luk KC, Sanders LH, Lee VM, Greenamyre JT. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Cell Mol Life Sci. 2017;74:2851\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"599_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbr.2018.02.014","volume":"344","author":"SE Park","year":"2018","unstructured":"Park SE, Song KI, Kim H, Chung S, Youn I. Graded 6-OHDA-induced dopamine depletion in the nigrostriatal pathway evokes progressive pathological neuronal activities in the subthalamic nucleus of a hemi-parkinsonian mouse. Behav Brain Res. 2018;344:42\u20137.","journal-title":"Behav Brain Res"},{"key":"599_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577694","volume":"359","author":"D Cossu","year":"2021","unstructured":"Cossu D, Yokoyama K, Sato S, Noda S, Sechi LA, Hattori N. PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol. 2021;359:577694.","journal-title":"J Neuroimmunol"},{"key":"599_CR60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","volume":"561","author":"DA Sliter","year":"2018","unstructured":"Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018;561:258\u201362.","journal-title":"Nature"},{"key":"599_CR61","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M, et al. Parkinson\u2019s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell. 2016;166:314\u201327.","journal-title":"Cell"},{"key":"599_CR62","doi-asserted-by":"crossref","unstructured":"Perego M, Yeon M, Agarwal E, Milcarek AT, Bertolini I, Camisaschi C, et al. Parkin activates innate immunity and promotes antitumor immune responses. J Clin Invest. 2025;135:e190291.","DOI":"10.1172\/JCI190291"},{"key":"599_CR63","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114:2283\u2013301.","journal-title":"Brain"},{"key":"599_CR64","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/0140-6736(90)91006-V","volume":"335","author":"CD Marsden","year":"1990","unstructured":"Marsden CD. Parkinson\u2019s disease. Lancet. 1990;335:948\u201352.","journal-title":"Lancet"},{"key":"599_CR65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cub.2019.11.079","volume":"30","author":"JY Heo","year":"2020","unstructured":"Heo JY, Nam MH, Yoon HH, Kim J, Hwang YJ, Won W, et al. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson\u2019s Disease. Curr Biol. 2020;30:276\u201391.e9.","journal-title":"Curr Biol"},{"key":"599_CR66","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.18632\/aging.103551","volume":"12","author":"H Chen","year":"2020","unstructured":"Chen H, Cao J, Zha L, Wang P, Liu Z, Guo B, et al. Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson\u2019s disease models through activating the MEF2-PGC1\u03b1 and BDNF\/CREB pathways. Aging (Albany NY). 2020;12:14897\u2013917.","journal-title":"Aging (Albany NY)"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00599-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:02:56Z","timestamp":1786611776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00599-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00599-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed according to the guidelines approved by the Animal Care and Use Committee of Shonan Health Innovation Park, that operates in full accordance with the Act on Welfare and Management of Animals (Act No. 105 of October 1, 1973) and the Standards relating to the Care and Keeping and Reducing Pain of Laboratory Animals (Notice No. 88 of the Ministry of Environment, 2006) (IACUC approval number: AU-00030499, AU-00030645, and AU-00031173).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors are employees of Takeda Pharmaceuticals. The study was funded solely by Takeda Pharmaceuticals.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}